ferric maltol: Clinical Trials

4 trials of ferric maltol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 terminated, 1 unknown. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 1, Recruiting 1, Terminated 1, Unknown 1

Follow ferric maltol: new trials by email Literature Review of ferric maltol trials Research Report on ferric maltol

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Women
Sucrosomial® Iron (Sideral® Forte), Ferric Maltol (Feraccru®) - Anemia, Iron Deficiency Anemia (IDA)
Phase 4RecruitingPharmanutra S.p.a.1462025-12-112026-09-03
ORal IrON Supplementation with Ferric Maltol in Treating Iron Deficiency and Anaemia in Patients with Heart Failure (ORION-HF)
Ferric maltol 30 mg (Feraccru®) - Heart Failure, Left-sided, Anemia, Iron Deficiency
Phase 4CompletedHannover Medical School502023-02-212025-03-07
Predicting Response to Iron Supplementation in Patients With Active Inflammatory Bowel Disease
Intravenous iron, Ferric maltol, Ferrous fumarate - Inflammatory Bowel Diseases, Iron-deficiency
Phase 4UnknownLeiden University Medical Center902022-08-192023-03-31
ORal IrON Supplementation With Ferric Maltol in Patients With Heart Failure Carrying Left Ventricular Assist Devices
Ferric maltol 30 mg (Feraccru®) - Heart Failure, Left Sided, Anemia, Iron Deficiency
Phase 4TerminatedHannover Medical School112019-03-182020-04-21

Conditions studied

Anemia, Iron-Deficiency (4)  ·  Iron Deficiencies (4)  ·  Heart Failure (2)  ·  Anemia (1)  ·  Colitis, Ulcerative (1)  ·  Crohn Disease (1)  ·  Inflammatory Bowel Diseases (1)

Sponsors

Hannover Medical School (2)  ·  Leiden University Medical Center (1)  ·  Pharmanutra S.p.a. (1)

Countries

Germany (2)  ·  Netherlands (1)  ·  Spain (1)

Top investigators

Jan Schmitto, Prof. MD (1)  ·  Johann Bauersachs, Prof. Dr. (1)

Results publications

PMID 38296290, PMID 42261111

NIH funding

2025 (1)